- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Incontinence, Urinary and Urinary Bladder, Overactive in Denmark
Total 1508 results
-
Vendsyssel HospitalUniversity of AarhusCompletedRed Clover Isoflavones in Postmenopausal Women With Urge Urinary Incontinence and Overactive BladderOveractive Bladder | Urge IncontinenceDenmark
-
University of AarhusCompletedOveractive Bladder | Urinary IncontinenceDenmark
-
University of AarhusCompletedOveractive Bladder | Urinary IncontinenceDenmark
-
Herlev and Gentofte HospitalRegion Hovedstadens ApotekRecruitingOveractive Bladder | Anesthesia, Local | Urinary Tract Infections | Pain, Procedural | Urge Incontinence | HematuriaDenmark
-
Astellas Pharma Europe Ltd.CompletedUrologic Diseases | Overactive Bladder | Urinary Bladder Diseases | Urgency Incontinence | Urinary Bladder OveractiveCzechia, Denmark, Greece, Ireland, Slovakia, Spain, Sweden, United Kingdom
-
InnoCon MedicalOdense University Hospital; Aarhus University Hospital; Herlev HospitalRecruitingUrinary Incontinence | Fecal Incontinence | Urinary Incontinence, Urge | Nocturia | Fecal Incontinence With Fecal Urgency | Urinary Frequency More Than Once at Night | Incontinence, Nighttime Urinary | Bowel Disorders FunctionalDenmark
-
Aalborg University HospitalAarhus University Hospital; Regional Hospital West Jutland; North Denmark Regional...RecruitingBehavioral Symptoms | Mental Disorders | Urologic Diseases | Lower Urinary Tract Symptoms | Urological Manifestations | Urinary Incontinence | Urination Disorders | Elimination Disorders | Daytime Wetting | Urination InvoluntaryDenmark
-
InnoCon MedicalOdense University Hospital; Aarhus University Hospital; Herlev HospitalCompletedUrinary Incontinence | Fecal Incontinence | Urge Incontinence | Urinary Incontinence, Urge | Nocturia | Urinary Frequency More Than Once at Night | Incontinence, Nighttime Urinary | Bowel Disorders FunctionalDenmark
-
Astellas Pharma Europe B.V.CompletedOveractive Bladder | Urgency Incontinence | Urinary Bladder Overactive | Urinary Bladder Diseases\Urologic DiseasesBelgium, Russian Federation, Korea, Republic of, United States, Germany, Spain, Australia, Bulgaria, Canada, Czechia, Denmark, Estonia, Finland, Hungary, Italy, Latvia, Lithuania, Malaysia, Mexico, Netherlands, New Zealand, Norway, ... and more
-
Astellas Pharma Europe B.V.CompletedOveractive Bladder | Urgency Incontinence | Urinary Bladder Overactive | Urinary Bladder Diseases\Urologic DiseasesUnited States, Argentina, Australia, Belgium, Bulgaria, Canada, China, Colombia, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Hong Kong, Hungary, Italy, Korea, Republic of, Latvia, Lithuania, Malaysia, Mexico, Netherlands and more
-
University of AarhusCompleted
-
Astellas Pharma Europe B.V.CompletedOveractive Bladder | Neurogenic Detrusor OveractivityDenmark, Poland
-
University of AarhusUniversity Hospital, GhentUnknown
-
Anne Estrup OlesenUniversity College of Northern DenmarkEnrolling by invitationOveractive Bladder | Deprescribing | PIMSDenmark
-
Astellas Pharma IncCompletedOveractive Bladder | Neurogenic Detrusor OveractivityBelgium, Canada, Denmark, Netherlands, Poland, Turkey, United Kingdom
-
Astellas Pharma IncAstellas Pharma Europe B.V.CompletedOveractive Bladder | Pharmacokinetics of Mirabegron | Neurogenic Detrusor OveractivityBelgium, Denmark, Norway, Poland, Serbia
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedOveractive Bladder (OAB)United States, Canada, Germany, Korea, Republic of, Spain, Turkey, Taiwan, Italy, Slovakia, Denmark, South Africa, United Kingdom, Mexico, Sweden, Norway
-
Astellas Pharma Europe Ltd.CompletedUrologic Diseases | Urinary Bladder Diseases | Urinary Bladder OveractiveUnited States, Armenia, Australia, Austria, Belgium, Canada, Czechia, Denmark, Finland, France, Georgia, Germany, Greece, Hungary, Ireland, Israel, Italy, Lebanon, Netherlands, Norway, Poland, Portugal, Romania, Russian Federation, Slov... and more
-
Herning HospitalNot yet recruitingBreast Cancer | Menopause | Vaginal Atrophy | Endometrial Cancer | Bladder, Overactive | Laser-Induced ScarDenmark
-
Rigshospitalet, DenmarkCopenhagen Academy for Medical Education and SimulationActive, not recruitingBladder Cancer | Virtual Reality | EducationDenmark
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveSweden, United Kingdom, Belgium, Denmark
-
Copenhagen University Hospital at HerlevZealand University HospitalTerminatedUrinary Incontinence | Interstitial Cystitis | Bladder DiseasesDenmark
-
PfizerCompletedOveractive BladderDenmark, United States, Canada, Costa Rica, Belgium, Czech Republic, Colombia, Germany, Hungary, Korea, Republic of, Spain, Chile, Taiwan, India, Brazil, Singapore, Greece, Hong Kong, Italy, Sweden, Poland, South Africa, Malaysia, Rom... and more
-
PfizerCompletedOveractive BladderKorea, Republic of, United States, Denmark, Germany, Canada, Hungary, Poland, France, United Kingdom, Slovakia, Sweden, Mexico, Czech Republic, Finland, Italy, Lithuania, Argentina, Chile, Colombia, Egypt, Greece, Norway, Philippines, Russian Federation and more
-
Astellas Pharma IncAstellas Pharma Europe B.V.CompletedOveractive BladderPoland, United Kingdom, Germany, Spain, Netherlands, Belgium, Czech Republic, Italy, Norway, Hungary, Sweden, Denmark, Greece, France, Russian Federation
-
Jørgen Bjerggaard JensenCompleted
-
Jørgen Bjerggaard JensenCepheidActive, not recruitingNon-muscle Invasive Bladder Cancer | Urinary BiomarkerDenmark
-
Rigshospitalet, DenmarkCopenhagen Academy for Medical Education and SimulationCompletedMedical Education | Bladder Cancer | Validity-evidence for a Simulator-based Test | Virtual Simulation | Surgical Skill Training | Transurethral Resection of BladdertumorsDenmark
-
Copenhagen University Hospital at HerlevZealand University HospitalTerminatedStress Urinary Incontinence | Urge Urinary IncontinenceDenmark
-
Astellas Pharma Europe B.V.CompletedUrinary Bladder, OveractiveBelgium, United States, Brazil, Canada, Denmark, Former Serbia and Montenegro, Korea, Republic of, Mexico, Norway, Philippines, Poland, South Africa, Sweden, Turkey, Ukraine, United Kingdom
-
Astellas Pharma Europe B.V.CompletedNeurogenic Detrusor OveractivityUnited States, Belgium, Brazil, Denmark, Hungary, Korea, Republic of, Mexico, Philippines, Poland, Turkey
-
Astellas Pharma Europe B.V.CompletedUrinary Bladder, OveractiveBelgium, United States, Brazil, Canada, Denmark, Former Serbia and Montenegro, Korea, Republic of, Mexico, Norway, Philippines, Poland, South Africa, Sweden, Turkey, Ukraine, United Kingdom
-
Zealand University HospitalCompletedUrinary Stress IncontinenceDenmark
-
Astellas Pharma Europe B.V.CompletedNeurogenic Detrusor OveractivityBelgium, Croatia, Turkey, Australia, Denmark, Israel, Jordan, Korea, Republic of, Latvia, Lithuania, Malaysia, Mexico, Norway, Philippines, Poland, Romania, Serbia, Slovakia, Taiwan
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveFrance, United Kingdom, Spain, Belarus, Belgium, Ukraine, Denmark, Greece, Russian Federation, Czech Republic, Netherlands, Germany, Hungary, Italy, Slovakia, Sweden, Norway
-
Astellas Pharma Global Development, Inc.RecruitingNeurogenic Detrusor OveractivityPhilippines, Turkey, Belgium, Denmark
-
University Hospital Bispebjerg and FrederiksbergCompletedFecal Incontinence | Urinary Incontinence,StressDenmark
-
Herlev HospitalCompletedUrinary Stress IncontinenceDenmark
-
PfizerCompletedUrinary Bladder, OveractivePortugal, Spain, Turkey, Finland, Germany, Norway, Sweden, Slovakia, Italy, Austria, United Kingdom, Belgium, Denmark, Israel, Switzerland
-
University Hospital Bispebjerg and FrederiksbergCompletedStress Urinary Incontinence | Fecal IncontinenceDenmark
-
PfizerCompletedStress Urinary IncontinenceDenmark
-
Glostrup University Hospital, CopenhagenUnknownUrge Urinary IncontinenceDenmark
-
University Hospital Bispebjerg and FrederiksbergUnknownBladder CancerDenmark
-
Varian, a Siemens Healthineers CompanyRigshospitalet, Denmark; Herlev HospitalRecruitingMuscle-Invasive Bladder CarcinomaDenmark
-
Copenhagen University Hospital at HerlevUnknown
-
Hvidovre University HospitalCompleted
-
Jørgen Bjerggaard JensenRecruiting
-
Aarhus University HospitalRecruiting
-
Herlev HospitalUnknown